SRRM5
gene geneOn this page
Summary
SRRM5 (serine/arginine repetitive matrix 5, HGNC:37248) is a protein-coding gene on chromosome 19q13.31, encoding Serine/arginine repetitive matrix protein 5 (B3KS81).
At a glance
- Clinical variants (ClinVar): 124 total
- MANE Select transcript:
NM_001145641
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37248 |
| Approved symbol | SRRM5 |
| Name | serine/arginine repetitive matrix 5 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000226763 |
| Ensembl biotype | protein_coding |
| Entrez | 100170229 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000417606, ENST00000607544
RefSeq mRNA: 1 — MANE Select: NM_001145641
NM_001145641
CCDS: CCDS46095
Canonical transcript exons
ENST00000417606 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001795929 | 43612088 | 43614498 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 90.81.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0830 / max 87.0594, expressed in 5 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176203 | 8.8225 | 1772 |
| 176205 | 0.0549 | 3 |
| 176204 | 0.0182 | 3 |
| 176206 | 0.0100 | 3 |
Top tissues by expression
244 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.81 | gold quality |
| right testis | UBERON:0004534 | 90.51 | gold quality |
| testis | UBERON:0000473 | 87.16 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.43 | gold quality |
| sperm | CL:0000019 | 74.69 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 66.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 66.19 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.98 | gold quality |
| cerebellum | UBERON:0002037 | 64.85 | gold quality |
| sural nerve | UBERON:0015488 | 64.15 | gold quality |
| stromal cell of endometrium | CL:0002255 | 62.49 | gold quality |
| apex of heart | UBERON:0002098 | 62.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 62.07 | gold quality |
| right lobe of liver | UBERON:0001114 | 62.00 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 61.83 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 61.63 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 61.42 | gold quality |
| superficial temporal artery | UBERON:0001614 | 60.99 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 60.81 | gold quality |
| heart right ventricle | UBERON:0002080 | 60.67 | gold quality |
| granulocyte | CL:0000094 | 60.61 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 60.55 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 60.43 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 60.42 | gold quality |
| adenohypophysis | UBERON:0002196 | 60.15 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 59.88 | gold quality |
| caudate nucleus | UBERON:0001873 | 59.84 | gold quality |
| putamen | UBERON:0001874 | 59.76 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 59.72 | gold quality |
| bone marrow cell | CL:0002092 | 59.71 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 9.31 |
| E-MTAB-9543 | yes | 6.68 |
| E-MTAB-6058 | no | 153.36 |
| E-ANND-3 | no | 0.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting SRRM5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-1303 | 99.65 | 69.77 | 1662 |
| HSA-MIR-7974 | 99.24 | 65.48 | 1137 |
| HSA-MIR-3925-5P | 99.21 | 67.90 | 1466 |
| HSA-MIR-4793-5P | 96.88 | 65.90 | 872 |
| HSA-MIR-6741-5P | 93.86 | 63.06 | 437 |
| HSA-MIR-6840-5P | 88.69 | 60.91 | 68 |
| HSA-MIR-4743-5P | 88.08 | 64.31 | 91 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm50092 | ENSMUSG00000117477 |
| rattus_norvegicus | AABR07002689.1 | ENSRNOG00000050032 |
Protein
Protein identifiers
Serine/arginine repetitive matrix protein 5 — B3KS81 (reviewed: B3KS81)
All UniProt accessions (1): B3KS81
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_001139113* (*=MANE)
Domains & families (InterPro)
UniProt features (25 total): compositionally biased region 18, sequence conflict 5, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B3KS81-F1 | 41.71 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, COBLL1_TARGET_GENES, CREB3L4_TARGET_GENES, DACH1_TARGET_GENES, DIDO1_TARGET_GENES, E2F2_TARGET_GENES, ELF2_TARGET_GENES, FEV_TARGET_GENES, H1_6_TARGET_GENES, HOXB6_TARGET_GENES, IRF5_TARGET_GENES, LMTK3_TARGET_GENES, MEF2D_TARGET_GENES, NCOA2_TARGET_GENES, NPAT_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
226 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SRRM5 | KRTAP13-2 | Q52LG2 | 667 |
| SRRM5 | OR1B1 | Q8NGR6 | 620 |
| SRRM5 | XKR5 | Q6UX68 | 599 |
| SRRM5 | PRSS45P | Q7RTY3 | 581 |
| SRRM5 | OR2A12 | Q8NGT7 | 505 |
| SRRM5 | CPNE7 | Q9UBL6 | 453 |
| SRRM5 | KRTAP1-1 | Q07627 | 435 |
| SRRM5 | CPNE6 | O95741 | 426 |
| SRRM5 | CPNE3 | O75131 | 385 |
| SRRM5 | CPNE1 | Q99829 | 379 |
| SRRM5 | CCDC88C | Q9P219 | 365 |
| SRRM5 | KLHL26 | Q53HC5 | 326 |
| SRRM5 | CPNE9 | Q8IYJ1 | 318 |
| SRRM5 | CPNE2 | Q96FN4 | 296 |
| SRRM5 | DIS3 | Q9Y2L1 | 277 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SRRM5 | LRRC59 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): LRRC59 (Proximity Label-MS), SRRM5 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GUY1, A6NJ88, A6QL64, B3KS81, E9Q6E9, O43493, O48582, O77733, P04279, P0C7A4, P0C7A5, P0CV57, P0DKJ7, P10322, P16225, P48997, P48998, Q02383, Q06990, Q08AG5, Q0ZNK1, Q5JPF3, Q5JRC9, Q5SRN2, Q5U7M7, Q5U7M8, Q5U7M9, Q5U7N0, Q5U7N1, Q5U7N3, Q5U7N4, Q5XHX6, Q659K0, Q6AYN3, Q6JHY2, Q6P902, Q6SJ82, Q6X2M3, Q6XPR3, Q80Y39
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 21 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1441 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:43597182:G:GT | donor_gain | 1.0000 |
| 19:43597189:CATCT:C | donor_gain | 1.0000 |
| 19:43597190:ATCT:A | donor_gain | 1.0000 |
| 19:43597191:TCT:T | donor_gain | 1.0000 |
| 19:43597192:CT:C | donor_gain | 1.0000 |
| 19:43597193:TGTG:T | donor_loss | 1.0000 |
| 19:43597194:G:GA | donor_loss | 1.0000 |
| 19:43597194:G:GG | donor_gain | 1.0000 |
| 19:43597195:TGAG:T | donor_loss | 1.0000 |
| 19:43597198:G:GG | donor_gain | 1.0000 |
| 19:43599208:G:GT | donor_gain | 1.0000 |
| 19:43608103:GGGGC:G | acceptor_gain | 1.0000 |
| 19:43608105:GGC:G | acceptor_gain | 1.0000 |
| 19:43608106:GC:G | acceptor_gain | 1.0000 |
| 19:43608107:CC:C | acceptor_gain | 1.0000 |
| 19:43608108:C:CA | acceptor_loss | 1.0000 |
| 19:43608108:C:CC | acceptor_gain | 1.0000 |
| 19:43608109:T:A | acceptor_loss | 1.0000 |
| 19:43614223:CCTTA:C | donor_loss | 1.0000 |
| 19:43614224:CTTAC:C | donor_loss | 1.0000 |
| 19:43614225:TTA:T | donor_loss | 1.0000 |
| 19:43614227:ACCT:A | donor_loss | 1.0000 |
| 19:43614228:C:G | donor_loss | 1.0000 |
| 19:43596742:GG:G | donor_gain | 0.9900 |
| 19:43596743:GG:G | donor_gain | 0.9900 |
| 19:43597093:GAA:G | acceptor_gain | 0.9900 |
| 19:43597196:GAGTA:G | donor_loss | 0.9900 |
| 19:43597197:A:AG | donor_gain | 0.9900 |
| 19:43597197:AGTA:A | donor_loss | 0.9900 |
| 19:43598829:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
4747 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:43613445:A:C | S442R | 0.838 |
| 19:43613447:T:A | S442R | 0.838 |
| 19:43613447:T:G | S442R | 0.838 |
| 19:43613067:A:C | S316R | 0.802 |
| 19:43613069:T:A | S316R | 0.802 |
| 19:43613069:T:G | S316R | 0.802 |
| 19:43613517:A:C | S466R | 0.794 |
| 19:43613519:T:A | S466R | 0.794 |
| 19:43613519:T:G | S466R | 0.794 |
| 19:43613409:A:C | S430R | 0.790 |
| 19:43613411:T:A | S430R | 0.790 |
| 19:43613411:T:G | S430R | 0.790 |
| 19:43612293:A:C | S58R | 0.789 |
| 19:43612295:C:A | S58R | 0.789 |
| 19:43612295:C:G | S58R | 0.789 |
| 19:43612302:A:C | S61R | 0.741 |
| 19:43612304:T:A | S61R | 0.741 |
| 19:43612304:T:G | S61R | 0.741 |
| 19:43613456:G:C | K445N | 0.738 |
| 19:43613456:G:T | K445N | 0.738 |
| 19:43613481:A:C | S454R | 0.711 |
| 19:43613483:T:A | S454R | 0.711 |
| 19:43613483:T:G | S454R | 0.711 |
| 19:43613060:G:C | R313S | 0.710 |
| 19:43613060:G:T | R313S | 0.710 |
| 19:43612404:A:C | S95R | 0.692 |
| 19:43612406:C:A | S95R | 0.692 |
| 19:43612406:C:G | S95R | 0.692 |
| 19:43613373:A:C | S418R | 0.678 |
| 19:43613375:T:A | S418R | 0.678 |
dbSNP variants (sampled 300 via entrez): RS1000401373 (19:43613417 C>A,T), RS1001004165 (19:43612530 A>C,G), RS1001050277 (19:43612736 G>A,T), RS1001206258 (19:43610254 C>T), RS1001843306 (19:43612821 C>T), RS1002861888 (19:43611654 T>C), RS1002933780 (19:43611476 C>T), RS1003050790 (19:43610256 G>A,C), RS1005254175 (19:43612368 C>A,T), RS1005563926 (19:43611789 GC>G,GCC), RS1005616382 (19:43612554 A>G,T), RS1006203608 (19:43611448 T>C), RS1006669173 (19:43611160 C>T), RS1007076052 (19:43612173 G>T), RS1007341510 (19:43613680 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Magnetite Nanoparticles | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.